3 Part Lecture - Community Acquired Pneumonia; Hospital and Ventilator Associated Pneumonia; and Tuberculosis (2026 IMCU)

Only available as part of a package

Learning Objectives:

Upon completion of this educational activity, participants will be able to utilize current ATS/IDSA guidelines to diagnose, assess severity, and select appropriate empiric antibiotic therapy for community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP) in adult patients.
Upon completion of this educational activity, participants will be able to select appropriate treatment regimens for drug-susceptible and drug-resistant tuberculosis, including NEW 2025 shortened regimens (4-month DS-TB, 6-month BPaL/BPaLM) based on patient eligibility and drug susceptibility testing.
Upon completion of this educational activity, participants will be able to recognize and apply major practice changes from recent guidelines (2019-2025), including elimination of HCAP category, shortened treatment durations, and new all-oral regimens for drug-resistant tuberculosis.

Patrick J. Kenney, DO, FACOI (he/him/his)

Vice Chair and Fellowship Program Director, Department of Infectious Diseases

Cleveland Clinic Florida

Patrick J. Kenney, D.O., F.A.C.O.I. Vice Chair, Department of Infectious Diseases, Cleveland Clinic Florida has been in clinical practice since 2013. Dr. Kenney completed his internal medicine training at Broward Health Medical Center in Fort Lauderdale, FL and his fellowhip in infectious diseases at Morsani College of Medicine at the University of South Florida in Tampa, FL. He is the newly appointed program director for the Infectious Disease fellowship program at the Cleveland Clinic Florida in Weston, FL. Dr. Kenney cares for patients across all aspects of the specialty in both the inpatient and outpatient setting. He is clinical adjunct faculty at Florida Atlantic University Charles E. Schmidt College of Medicine, Ross University College of Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine at Nova Southeastern University, and St. George's University College of Medicine. His clincal interests include virology particularly HIV as well as transplant infectious diseases.

The faculty member, for this activity, has no relevant relationships with ineligible companies to disclose.